Shopping Cart 0
Cart Subtotal
AED 0

Blood Glucose Test Strips - Medical Devices Pipeline Assessment, 2019

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 9175

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 18350

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 27525

Details

Blood Glucose Test Strips-Medical Devices Pipeline Assessment, 2019

Summary

GlobalData's Medical Devices sector report, Blood Glucose Test Strips-Medical Devices Pipeline Assessment, 2019" provides an overview of Blood Glucose Test Strips currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Blood Glucose Test Strips pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Blood Glucose Test Strips under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Blood Glucose Test Strips and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry.

Reasons to buy

The report enables you to-

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Blood Glucose Test Strips under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date.

READ MORE

Table Of Content

Scope

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Blood Glucose Test Strips Overview

3 Products under Development

3.1 Blood Glucose Test Strips-Pipeline Products by Stage of Development

3.2 Blood Glucose Test Strips-Pipeline Products by Territory

3.3 Blood Glucose Test Strips-Pipeline Products by Regulatory Path

3.4 Blood Glucose Test Strips-Pipeline Products by Estimated Approval Date

4 Blood Glucose Test Strips-Pipeline Products under Development by Companies

4.1 Blood Glucose Test Strips Companies-Pipeline Products by Stage of Development

4.2 Blood Glucose Test Strips-Pipeline Products by Stage of Development

5 Blood Glucose Test Strips Companies and Product Overview

5.1 Accessible Diagnostics LLC Company Overview

5.2 Achira Labs Pvt Ltd Company Overview

5.3 DirectSens GmbH Company Overview

5.4 Gluco-Chaser Inc Company Overview

5.5 PharmaTech Solutions Inc Company Overview

6 Blood Glucose Test Strips- Recent Developments

6.1 Jun 11, 2019: Changes in Roche's board of directors and corporate executive committee

6.2 Jun 11, 2019: Regulators demand more details on Roche's USD 4.8bn Spark acquisition

6.3 May 28, 2019: LifeScan names Alisandra Rizzolo Head of Transformation

6.4 May 22, 2019: Serving the needs of the medical front and creating new value the start of a New Medical Device and Reagent Brand: "The Lab"

6.5 May 20, 2019: LifeScan Names Ty Lee Head of Marketing

6.6 May 09, 2019: Senseonics Holdings reports first quarter 2019 financial results

6.7 May 09, 2019: DECN sets plan to make upcoming patent infringement appeal hearing and mediation with Johnson & Johnson a foundation for substantial recovery

6.8 Apr 26, 2019: Nationally recognized expert in consumerism joins Henry Ford Health System

6.9 Apr 23, 2019: In Prelude to probable transaction DECN decides to infuse its outre' precise, TBG technology to its GenChoice Test Strip, now in FDA 510k review

6.10 Apr 23, 2019: Universal Biosensors: Commentary on Q1 2019 appendix 4C cash flow summary

6.11 Apr 17, 2019: DECN expands talks involving its GenUltimate TBG System, balances potential and competing outcomes with recent intro to 2nd interested party

6.12 Apr 17, 2019: Roche reports a strong start in 2019 and raises the outlook for the full-year

6.13 Apr 17, 2019: Abbott reports first-quarter 2019 results

6.14 Apr 09, 2019: Henry Ford Health System names two new senior leaders

6.15 Apr 08, 2019: LifeScan names Brian Heald as its new Head of Product

6.16 Apr 01, 2019: Mologic expands US and UK operations

6.17 Mar 21, 2019: Roche sues U.S. executives in fight over diabetes test strips

6.18 Mar 19, 2019: Abbott introduces new digital service in India as part of its global a: care program

6.19 Mar 13, 2019: EKF Diagnostics Holdings: Final results

6.20 Mar 08, 2019: Universal Biosensors announces resignation of CEO Rick Legleiter

6.21 Mar 06, 2019: Senseonics Holdings appoints Francine R. Kaufman, M.D. as chief medical officer

6.22 Feb 22, 2019: Abbott planning USD 62M expansion in Columbus, adding 38 jobs

6.23 Feb 05, 2019: Confluent Medical Technologies launches the high-performance nitinol tubing center of excellence

6.24 Jan 31, 2019: Roche reports very strong results in 2018

6.25 Jan 30, 2019: DECN subsidiary receives 510k submission and ''K'' numbers from FDA CDRH for Its Genchoice! Test Strip at the close of the government shutdown

6.26 Jan 29, 2019: Universal Biosensors: Commentary on FY 2018

6.27 Jan 24, 2019: Genentech announces Alexander Hardy as Chief Executive Officer

6.28 Jan 23, 2019: Abbott reports 2018 results and issues strong forecast for 2019

6.29 Jan 21, 2019: ARKRAY USA launches Assure Slide swallowing aid

6.30 Jan 10, 2019: ARKRAY Commences Overseas Remote Maintenance Services for Medical Devices

6.31 Jan 09, 2019: STANDARD GlucoNavii GDH now available for newborn testing

6.32 Jan 07, 2019: Senseonics Holdings names Jon D. Isaacson as chief financial officer

6.33 Jan 02, 2019: Roche Diabetes Care India appoints Dr. Gaurav Laroia as general manager

6.34 Dec 20, 2018: Strengthening Global Research and Development Networks AI Software Development facility established in India

6.35 Dec 20, 2018: Universal Biosensors provides business update

6.36 Dec 19, 2018: DECN Subsidiaries Appeal Nevada District Court Trial Judge's Ruling to U.S. Court of Appeals for the Federal Circuit (The Patent Appeals Court)

6.37 Dec 17, 2018: DECN Engages second Korean manufacturing partner to raise its factory capacity by two million boxes of ''GEN'' test strips annually

6.38 Dec 10, 2018: New member proposed for election to Roche Board of Directors

6.39 Dec 10, 2018: ARKRAY USA changes name of long-term care division to professional healthcare division

6.40 Dec 10, 2018: Roche names William Anderson as CEO

6.41 Dec 10, 2018: Roche names William Bill Anderson as CEO from January 01 2019

6.42 Dec 04, 2018: DECN receives completed clinical trials report from its IRB and anticipates filing its U.S. FDA 510k application for its Genchoice! product

6.43 Dec 04, 2018: ARKRAY expands to its 13th Country with a new branch in Dubai

6.44 Dec 03, 2018: Senseonics Holdings announces retirement of Chief Financial Officer

6.45 Dec 03, 2018: Roche to increase its payroll in Switzerland by 1.2 percent

6.46 Nov 26, 2018: Henry Ford Health System announced Dr. Betty Chu appointments

6.47 Nov 08, 2018: Senseonics Holdings reports third quarter 2018 financial results

6.48 Nov 07, 2018: LifeScan unveils new name and branding for the LifeScan Diabetes Institute

6.49 Nov 06, 2018: DECN receives completed clinical trial data, charts and spreadsheets essential for its imminent Genchoice! Test Strip

6.50 Oct 30, 2018: Universal Biosensors releases Q3 FY2018 results

6.51 Oct 17, 2018: Roche reports very strong growth in the first nine months of 2018

6.52 Oct 17, 2018: Roche reports sales growth as new drugs ease pressure from biosimilar competition

6.53 Oct 17, 2018: Abbott Reports Third-Quarter 2018 Results

6.54 Oct 15, 2018: Abbott names Robert B. Ford President, Chief Operating Officer

6.55 Oct 03, 2018: J&J concludes sale of LifeScan to Platinum Equity for USD 2.1bn

6.56 Sep 19, 2018: EKF Diagnostics: Half yearly report

6.57 Sep 13, 2018: Roche ranked the most sustainable healthcare company in the Dow Jones Sustainability Indices for the tenth year running

6.58 Sep 13, 2018: Abbott is named global industry leader in sustainability for the sixth consecutive year on the Dow Jones Sustainability Index (DJSI)

6.59 Aug 24, 2018: Cadila Healthcare's Biologics manufacturing facility successfully completes USFDA inspection

6.60 Aug 14, 2018: DECN announces significant updates for products and programs

6.61 Aug 14, 2018: DECN Announces Significant Updates For Products And Programs

6.62 Aug 08, 2018: Senseonics Holdings reports second quarter 2018 financial results

6.63 Aug 01, 2018: Global Healthcare Organizations join Abbott to launch the UNIVANTS of Healthcare Excellence Award

6.64 Jul 26, 2018: Roche reports very strong performance in the first half of 2018

6.65 Jul 19, 2018: Universal Biosensors Announces Q2 Appendix 4C Cash F low Summary

6.66 Jul 18, 2018: Abbott reports second-Quarter 2018 Results

7 Appendix

7.1 Methodology

7.2 About GlobalData

7.3 Contact Us

7.4 Disclaimer


List Of Figure

1.2 List of Figures

Figure 1: Blood Glucose Test Strips-Pipeline Products by Stage of Development

Figure 2: Blood Glucose Test Strips-Pipeline Products by Territory

Figure 3: Blood Glucose Test Strips-Pipeline Products by Regulatory Path

Figure 4: Blood Glucose Test Strips-Pipeline Products by Estimated Approval Date


List Of Table

1.1 List of Tables

Table 1: Blood Glucose Test Strips-Pipeline Products by Stage of Development

Table 2: Blood Glucose Test Strips-Pipeline Products by Territory

Table 3: Blood Glucose Test Strips-Pipeline Products by Regulatory Path

Table 4: Blood Glucose Test Strips-Pipeline Products by Estimated Approval Date

Table 5: Blood Glucose Test Strips Companies-Pipeline Products by Stage of Development

Table 6: Blood Glucose Test Strips-Pipeline Products by Stage of Development

Table 7: Accessible Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview

Table 8: Life-Tab-Product Status

Table 9: Life-Tab-Product Description

Table 10: Achira Labs Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview

Table 11: Silk Strip-Diabetes-Product Status

Table 12: Silk Strip-Diabetes-Product Description

Table 13: DirectSens GmbH Pipeline Products & Ongoing Clinical Trials Overview

Table 14: Blood Glucose Test Strip-Product Status

Table 15: Blood Glucose Test Strip-Product Description

Table 16: Gluco-Chaser Inc Pipeline Products & Ongoing Clinical Trials Overview

Table 17: Disposable Strip BGM Prototype Sensor-Product Status

Table 18: Disposable Strip BGM Prototype Sensor-Product Description

Table 19: PharmaTech Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview

Table 20: Alltara Choice-Product Status

Table 21: Alltara Choice-Product Description

Table 22: GenAccord-Product Status

Table 23: GenAccord-Product Description

Table 24: GenSure Test Strip-Product Status

Table 25: GenSure Test Strip-Product Description

Table 26: Glossary

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Accessible Diagnostics LLC, Life-Tab, Diabetes Mellitus; Achira Labs Pvt Ltd, Silk Strip - Diabetes, Fabric Chip Technology, Diabetes Mellitus; DirectSens GmbH, Blood Glucose Test Strip, DirectSens Biosensor Technology, Diabetes Mellitus; Gluco-Chaser Inc, Disposable Strip BGM Prototype Sensor, Diabetes Mellitus; PharmaTech Solutions Inc, Alltara Choice, Diabetes Insipidus; PharmaTech Solutions Inc, Alltara Choice, Diabetes Mellitus; PharmaTech Solutions Inc, GenAccord, Diabetes Mellitus; PharmaTech Solutions Inc, GenSure Test Strip, Diabetes Mellitus


Companies

Accessible Diagnostics LLC

Achira Labs Pvt Ltd

DirectSens GmbH

Gluco-Chaser Inc

PharmaTech Solutions Inc

Company Profile

Company Profile Title

Blood Glucose Test Strips-Medical Devices Pipeline Assessment, 2019

Summary

GlobalData's Medical Devices sector report, Blood Glucose Test Strips-Medical Devices Pipeline Assessment, 2019" provides an overview of Blood Glucose Test Strips currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Blood Glucose Test Strips pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Blood Glucose Test Strips under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Blood Glucose Test Strips and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry.

Reasons to buy

The report enables you to-

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Blood Glucose Test Strips under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date.

READ MORE

Scope

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Blood Glucose Test Strips Overview

3 Products under Development

3.1 Blood Glucose Test Strips-Pipeline Products by Stage of Development

3.2 Blood Glucose Test Strips-Pipeline Products by Territory

3.3 Blood Glucose Test Strips-Pipeline Products by Regulatory Path

3.4 Blood Glucose Test Strips-Pipeline Products by Estimated Approval Date

4 Blood Glucose Test Strips-Pipeline Products under Development by Companies

4.1 Blood Glucose Test Strips Companies-Pipeline Products by Stage of Development

4.2 Blood Glucose Test Strips-Pipeline Products by Stage of Development

5 Blood Glucose Test Strips Companies and Product Overview

5.1 Accessible Diagnostics LLC Company Overview

5.2 Achira Labs Pvt Ltd Company Overview

5.3 DirectSens GmbH Company Overview

5.4 Gluco-Chaser Inc Company Overview

5.5 PharmaTech Solutions Inc Company Overview

6 Blood Glucose Test Strips- Recent Developments

6.1 Jun 11, 2019: Changes in Roche's board of directors and corporate executive committee

6.2 Jun 11, 2019: Regulators demand more details on Roche's USD 4.8bn Spark acquisition

6.3 May 28, 2019: LifeScan names Alisandra Rizzolo Head of Transformation

6.4 May 22, 2019: Serving the needs of the medical front and creating new value the start of a New Medical Device and Reagent Brand: "The Lab"

6.5 May 20, 2019: LifeScan Names Ty Lee Head of Marketing

6.6 May 09, 2019: Senseonics Holdings reports first quarter 2019 financial results

6.7 May 09, 2019: DECN sets plan to make upcoming patent infringement appeal hearing and mediation with Johnson & Johnson a foundation for substantial recovery

6.8 Apr 26, 2019: Nationally recognized expert in consumerism joins Henry Ford Health System

6.9 Apr 23, 2019: In Prelude to probable transaction DECN decides to infuse its outre' precise, TBG technology to its GenChoice Test Strip, now in FDA 510k review

6.10 Apr 23, 2019: Universal Biosensors: Commentary on Q1 2019 appendix 4C cash flow summary

6.11 Apr 17, 2019: DECN expands talks involving its GenUltimate TBG System, balances potential and competing outcomes with recent intro to 2nd interested party

6.12 Apr 17, 2019: Roche reports a strong start in 2019 and raises the outlook for the full-year

6.13 Apr 17, 2019: Abbott reports first-quarter 2019 results

6.14 Apr 09, 2019: Henry Ford Health System names two new senior leaders

6.15 Apr 08, 2019: LifeScan names Brian Heald as its new Head of Product

6.16 Apr 01, 2019: Mologic expands US and UK operations

6.17 Mar 21, 2019: Roche sues U.S. executives in fight over diabetes test strips

6.18 Mar 19, 2019: Abbott introduces new digital service in India as part of its global a: care program

6.19 Mar 13, 2019: EKF Diagnostics Holdings: Final results

6.20 Mar 08, 2019: Universal Biosensors announces resignation of CEO Rick Legleiter

6.21 Mar 06, 2019: Senseonics Holdings appoints Francine R. Kaufman, M.D. as chief medical officer

6.22 Feb 22, 2019: Abbott planning USD 62M expansion in Columbus, adding 38 jobs

6.23 Feb 05, 2019: Confluent Medical Technologies launches the high-performance nitinol tubing center of excellence

6.24 Jan 31, 2019: Roche reports very strong results in 2018

6.25 Jan 30, 2019: DECN subsidiary receives 510k submission and ''K'' numbers from FDA CDRH for Its Genchoice! Test Strip at the close of the government shutdown

6.26 Jan 29, 2019: Universal Biosensors: Commentary on FY 2018

6.27 Jan 24, 2019: Genentech announces Alexander Hardy as Chief Executive Officer

6.28 Jan 23, 2019: Abbott reports 2018 results and issues strong forecast for 2019

6.29 Jan 21, 2019: ARKRAY USA launches Assure Slide swallowing aid

6.30 Jan 10, 2019: ARKRAY Commences Overseas Remote Maintenance Services for Medical Devices

6.31 Jan 09, 2019: STANDARD GlucoNavii GDH now available for newborn testing

6.32 Jan 07, 2019: Senseonics Holdings names Jon D. Isaacson as chief financial officer

6.33 Jan 02, 2019: Roche Diabetes Care India appoints Dr. Gaurav Laroia as general manager

6.34 Dec 20, 2018: Strengthening Global Research and Development Networks AI Software Development facility established in India

6.35 Dec 20, 2018: Universal Biosensors provides business update

6.36 Dec 19, 2018: DECN Subsidiaries Appeal Nevada District Court Trial Judge's Ruling to U.S. Court of Appeals for the Federal Circuit (The Patent Appeals Court)

6.37 Dec 17, 2018: DECN Engages second Korean manufacturing partner to raise its factory capacity by two million boxes of ''GEN'' test strips annually

6.38 Dec 10, 2018: New member proposed for election to Roche Board of Directors

6.39 Dec 10, 2018: ARKRAY USA changes name of long-term care division to professional healthcare division

6.40 Dec 10, 2018: Roche names William Anderson as CEO

6.41 Dec 10, 2018: Roche names William Bill Anderson as CEO from January 01 2019

6.42 Dec 04, 2018: DECN receives completed clinical trials report from its IRB and anticipates filing its U.S. FDA 510k application for its Genchoice! product

6.43 Dec 04, 2018: ARKRAY expands to its 13th Country with a new branch in Dubai

6.44 Dec 03, 2018: Senseonics Holdings announces retirement of Chief Financial Officer

6.45 Dec 03, 2018: Roche to increase its payroll in Switzerland by 1.2 percent

6.46 Nov 26, 2018: Henry Ford Health System announced Dr. Betty Chu appointments

6.47 Nov 08, 2018: Senseonics Holdings reports third quarter 2018 financial results

6.48 Nov 07, 2018: LifeScan unveils new name and branding for the LifeScan Diabetes Institute

6.49 Nov 06, 2018: DECN receives completed clinical trial data, charts and spreadsheets essential for its imminent Genchoice! Test Strip

6.50 Oct 30, 2018: Universal Biosensors releases Q3 FY2018 results

6.51 Oct 17, 2018: Roche reports very strong growth in the first nine months of 2018

6.52 Oct 17, 2018: Roche reports sales growth as new drugs ease pressure from biosimilar competition

6.53 Oct 17, 2018: Abbott Reports Third-Quarter 2018 Results

6.54 Oct 15, 2018: Abbott names Robert B. Ford President, Chief Operating Officer

6.55 Oct 03, 2018: J&J concludes sale of LifeScan to Platinum Equity for USD 2.1bn

6.56 Sep 19, 2018: EKF Diagnostics: Half yearly report

6.57 Sep 13, 2018: Roche ranked the most sustainable healthcare company in the Dow Jones Sustainability Indices for the tenth year running

6.58 Sep 13, 2018: Abbott is named global industry leader in sustainability for the sixth consecutive year on the Dow Jones Sustainability Index (DJSI)

6.59 Aug 24, 2018: Cadila Healthcare's Biologics manufacturing facility successfully completes USFDA inspection

6.60 Aug 14, 2018: DECN announces significant updates for products and programs

6.61 Aug 14, 2018: DECN Announces Significant Updates For Products And Programs

6.62 Aug 08, 2018: Senseonics Holdings reports second quarter 2018 financial results

6.63 Aug 01, 2018: Global Healthcare Organizations join Abbott to launch the UNIVANTS of Healthcare Excellence Award

6.64 Jul 26, 2018: Roche reports very strong performance in the first half of 2018

6.65 Jul 19, 2018: Universal Biosensors Announces Q2 Appendix 4C Cash F low Summary

6.66 Jul 18, 2018: Abbott reports second-Quarter 2018 Results

7 Appendix

7.1 Methodology

7.2 About GlobalData

7.3 Contact Us

7.4 Disclaimer


List Of Figure

1.2 List of Figures

Figure 1: Blood Glucose Test Strips-Pipeline Products by Stage of Development

Figure 2: Blood Glucose Test Strips-Pipeline Products by Territory

Figure 3: Blood Glucose Test Strips-Pipeline Products by Regulatory Path

Figure 4: Blood Glucose Test Strips-Pipeline Products by Estimated Approval Date


List Of Table

1.1 List of Tables

Table 1: Blood Glucose Test Strips-Pipeline Products by Stage of Development

Table 2: Blood Glucose Test Strips-Pipeline Products by Territory

Table 3: Blood Glucose Test Strips-Pipeline Products by Regulatory Path

Table 4: Blood Glucose Test Strips-Pipeline Products by Estimated Approval Date

Table 5: Blood Glucose Test Strips Companies-Pipeline Products by Stage of Development

Table 6: Blood Glucose Test Strips-Pipeline Products by Stage of Development

Table 7: Accessible Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview

Table 8: Life-Tab-Product Status

Table 9: Life-Tab-Product Description

Table 10: Achira Labs Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview

Table 11: Silk Strip-Diabetes-Product Status

Table 12: Silk Strip-Diabetes-Product Description

Table 13: DirectSens GmbH Pipeline Products & Ongoing Clinical Trials Overview

Table 14: Blood Glucose Test Strip-Product Status

Table 15: Blood Glucose Test Strip-Product Description

Table 16: Gluco-Chaser Inc Pipeline Products & Ongoing Clinical Trials Overview

Table 17: Disposable Strip BGM Prototype Sensor-Product Status

Table 18: Disposable Strip BGM Prototype Sensor-Product Description

Table 19: PharmaTech Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview

Table 20: Alltara Choice-Product Status

Table 21: Alltara Choice-Product Description

Table 22: GenAccord-Product Status

Table 23: GenAccord-Product Description

Table 24: GenSure Test Strip-Product Status

Table 25: GenSure Test Strip-Product Description

Table 26: Glossary

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Accessible Diagnostics LLC, Life-Tab, Diabetes Mellitus; Achira Labs Pvt Ltd, Silk Strip - Diabetes, Fabric Chip Technology, Diabetes Mellitus; DirectSens GmbH, Blood Glucose Test Strip, DirectSens Biosensor Technology, Diabetes Mellitus; Gluco-Chaser Inc, Disposable Strip BGM Prototype Sensor, Diabetes Mellitus; PharmaTech Solutions Inc, Alltara Choice, Diabetes Insipidus; PharmaTech Solutions Inc, Alltara Choice, Diabetes Mellitus; PharmaTech Solutions Inc, GenAccord, Diabetes Mellitus; PharmaTech Solutions Inc, GenSure Test Strip, Diabetes Mellitus


Companies

Accessible Diagnostics LLC

Achira Labs Pvt Ltd

DirectSens GmbH

Gluco-Chaser Inc

PharmaTech Solutions Inc